Office of the Vice President for Global Communications

Thursday, June 24, 2010

The massive spill that continues to spew oil into the Gulf of Mexico will take a toll on the Gulf’s ecosystems and coastline communities for years to come, says David Uhlmann, Jeffrey F. Liss Professor from Practice and director of the Environmental Law and Policy Program at the Law School. In this video, he discusses why it’s time to revisit federal laws designed to protect the environment, and whether top officials at the companies involved may face criminal charges.

Alcohol Management Program participant now healthier, happier
A participant in MHealthy’s Alcohol Management Program describes how the program helped return him to a healthy lifestyle. The AMP, which is free to U-M employees, helps educate people so they can eliminate alcohol-related problems by reducing or stopping drinking.

Sports-themed event to help Cancer Center celebrate men's health
In recognition of June as national Men's Health Month, the Comprehensive Cancer Center will host a Men's Health and Fitness Day on Saturday at the Marriott Conference Center at Eagle Crest, 1275 S. Huron St., Ypsilanti. The free, sports-themed event will explore a number of men’s health issues. All men and teenage boys are invited to attend.

Alum wins Emerging Scholars Prize from Institute for the Humanities
The Institute for the Humanities has named Nathan Connolly, an assistant professor at Johns Hopkins University who received his doctorate in history from U-M, as the winner of the third annual Emerging Scholars Prize. The award recognizes scholars who push academic boundaries and are within five years of having received their doctorates.

The Michigan Difference

Personalized medicine
Seeking to understand why people react differently to a particular medication or dosage, scientists now are focusing on pharmacogenomics, the study of how a person's genome affects response to a specific drug. Vicki Ellingrod, associate professor of pharmacy and psychiatry, heads up the Clinical Pharmacogenomics Laboratory where she has studied the risk factors of metabolic syndrome, a major side effect for people taking schizophrenia drugs.